comparemela.com

Jama Oncology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AE Analysis Finds Low Rate of T-Cell Malignant Neoplasms in CAR T Recipients

Only 11 cases of adverse events (AEs) were reported over a 6-year time frame, the investigators found, following administration of chimeric antigen receptor T-cell therapy (CAR T).

vimarsana © 2020. All Rights Reserved.